APRACLONIDINE

APRACLONIDINE was reported 111 times

APRACLONIDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IRIS CONVEX 2 0.6667
1 VITREOUS PROLAPSE 1 0.0417
2 TRABECULECTOMY 3 0.0326
3 MALIGNANT MELANOMA OF SITES OTHER THAN SKIN 1 0.0196
4 MENINGIOMA MALIGNANT 1 0.0164
5 STERILE PYURIA 1 0.0156
6 CONJUNCTIVAL SCAR 2 0.0132
7 RETINAL PIGMENT EPITHELIOPATHY 4 0.0093
8 CRYSTALLURIA 4 0.0074
9 FLAT ANTERIOR CHAMBER OF EYE 1 0.0056
10 CHOROIDAL HAEMORRHAGE 1 0.0052
11 CHORIORETINAL DISORDER 1 0.0051
12 VITRECTOMY 3 0.0050
13 CHOROIDAL EFFUSION 4 0.0050
14 BREATHING-RELATED SLEEP DISORDER 1 0.0042
15 CORNEAL DEGENERATION 1 0.0041
16 SYMBLEPHARON 1 0.0038
17 HYPHAEMA 2 0.0038
18 BULBAR PALSY 1 0.0036
19 TRICHIASIS 1 0.0031
20 ILEOSTOMY CLOSURE 1 0.0030
21 FLOPPY IRIS SYNDROME 1 0.0027
22 EXTRAOCULAR MUSCLE PARESIS 1 0.0022
23 WOUND NECROSIS 1 0.0021
24 INTRAOCULAR PRESSURE DECREASED 1 0.0019
25 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 2 0.0018
26 ANGLE CLOSURE GLAUCOMA 4 0.0016
27 BROW PTOSIS 1 0.0015
28 MITRAL VALVE STENOSIS 1 0.0015
29 CORNEAL ABRASION 2 0.0015
30 CRANIAL NERVE DISORDER 1 0.0014
31 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
32 REACTION TO PRESERVATIVES 1 0.0012
33 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
34 URETEROLITHIASIS 1 0.0010
35 CORNEAL OEDEMA 2 0.0009
36 PUPILS UNEQUAL 1 0.0009
37 INFECTION REACTIVATION 1 0.0009
38 MACULOPATHY 3 0.0008
39 RETINAL DISORDER 2 0.0008
40 PHARYNGEAL ULCERATION 1 0.0008
41 EYELID PTOSIS 6 0.0006
42 TONGUE COATED 1 0.0006
43 OTORRHOEA 1 0.0006
44 CYSTOID MACULAR OEDEMA 1 0.0005
45 SINUS BRADYCARDIA 5 0.0005
46 OCULAR HYPERTENSION 1 0.0005
47 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
48 VARICELLA ZOSTER VIRUS INFECTION 1 0.0005
49 TENDERNESS 5 0.0005
50 ANURIA 4 0.0005
51 SPUTUM INCREASED 1 0.0005
52 CORNEAL DISORDER 1 0.0005
53 PARESIS 1 0.0004
54 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
55 VAGINAL INFECTION 2 0.0004
56 MYOPIA 1 0.0004
57 VITREOUS HAEMORRHAGE 1 0.0004
58 MASTICATION DISORDER 1 0.0003
59 RETINAL DETACHMENT 3 0.0003
60 IRIDOCYCLITIS 1 0.0003
61 HYPOVENTILATION 1 0.0003
62 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
63 RETINOPATHY 1 0.0003
64 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
65 ABNORMAL SENSATION IN EYE 1 0.0002
66 OCULAR ICTERUS 1 0.0002
67 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
68 GLAUCOMA 4 0.0002
69 PERIORBITAL OEDEMA 1 0.0002
70 MACULAR OEDEMA 1 0.0002
71 OCULAR DISCOMFORT 2 0.0002
72 CORONARY ARTERY BYPASS 1 0.0002
73 SINUS HEADACHE 1 0.0002
74 MACULAR DEGENERATION 2 0.0002
75 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
76 ADRENAL INSUFFICIENCY 2 0.0002
77 INTRAOCULAR PRESSURE INCREASED 2 0.0002
78 VISUAL ACUITY REDUCED 5 0.0002
79 URINARY RETENTION 5 0.0001
80 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
81 EXTRASYSTOLES 1 0.0001
82 RETINAL HAEMORRHAGE 1 0.0001
83 VISUAL FIELD DEFECT 1 0.0001
84 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
85 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
86 MIOSIS 1 0.0001
87 RHINITIS 1 0.0001
88 MYASTHENIA GRAVIS 1 0.0001
89 BLOOD MAGNESIUM DECREASED 1 0.0001
90 RESPIRATORY RATE INCREASED 1 0.0001
91 PHOTOPHOBIA 2 0.0001
92 RECALLED PRODUCT ADMINISTERED 1 0.0001
93 EYE INFLAMMATION 1 0.0001
94 HYPOTONIA 1 0.0001
95 HYPOTHERMIA 1 0.0001
96 EYE DISCHARGE 1 0.0001
97 BODY HEIGHT DECREASED 1 0.0001
98 OESOPHAGITIS 1 0.0001
99 EYE PAIN 5 0.0001
100 EYE INFECTION 1 0.0001
101 OCULAR HYPERAEMIA 4 0.0001
102 BACTERAEMIA 1 0.0001
103 SMALL INTESTINAL OBSTRUCTION 1 0.0001
104 EYE SWELLING 3 0.0001
105 UNRESPONSIVE TO STIMULI 2 0.0001
106 BRADYCARDIA 4 0.0001
107 PARALYSIS 1 0.0001
108 EYE IRRITATION 4 0.0001
109 APATHY 1 0.0001
110 METABOLIC ACIDOSIS 2 0.0001
111 DRY MOUTH 5 0.0001
112 EYE PRURITUS 2 0.0001
113 HEMIPARESIS 1 0.0001
114 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
115 MUSCULOSKELETAL DISCOMFORT 1 0.0001
116 BLOOD GLUCOSE ABNORMAL 1 0.0001
117 CONJUNCTIVITIS 1 0.0001
118 PRODUCT PRESCRIBING ISSUE 1 0.0000
119 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
120 STEVENS-JOHNSON SYNDROME 1 0.0000
121 GLOSSODYNIA 1 0.0000
122 CHROMATURIA 1 0.0000
123 VISION BLURRED 6 0.0000
124 DRY EYE 2 0.0000
125 ERECTILE DYSFUNCTION 1 0.0000
126 MUCOSAL INFLAMMATION 1 0.0000
127 SEDATION 1 0.0000
128 GASTRITIS 1 0.0000
129 EAR INFECTION 1 0.0000
130 JAUNDICE 1 0.0000
131 BLOOD BILIRUBIN INCREASED 1 0.0000
132 PALLOR 1 0.0000
133 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
134 PAIN IN JAW 1 0.0000
135 SOMNOLENCE 7 0.0000
136 LIVER FUNCTION TEST ABNORMAL 1 0.0000
137 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
138 HAEMATURIA 1 0.0000
139 GASTRIC DISORDER 1 0.0000
140 INJECTION SITE REACTION 2 0.0000
141 HEART RATE DECREASED 1 0.0000
142 SLEEP DISORDER 2 0.0000
143 CRYING 1 0.0000
144 HYPERGLYCAEMIA 1 0.0000
145 DYSARTHRIA 1 0.0000
146 ACUTE KIDNEY INJURY 4 0.0000
147 DISEASE PROGRESSION 3 0.0000
148 CARDIAC ARREST 2 0.0000
149 VISUAL IMPAIRMENT 3 0.0000
150 MENTAL DISORDER 1 0.0000
151 CONSTIPATION 5 0.0000
152 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
153 HYPOKALAEMIA 1 0.0000
154 ARRHYTHMIA 1 0.0000
155 DRUG INTOLERANCE 2 0.0000
156 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
157 OXYGEN SATURATION DECREASED 1 0.0000
158 CONVULSION 1 0.0000
159 LETHARGY 1 0.0000
160 NASAL CONGESTION 1 0.0000
161 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
162 DRUG INEFFECTIVE 21 0.0000
163 PRODUCT DOSE OMISSION 1 0.0000
164 RESPIRATORY FAILURE 1 0.0000
165 DIABETES MELLITUS 1 0.0000
166 INJECTION SITE SWELLING 1 0.0000
167 DRUG INTERACTION 2 0.0000
168 PROSTATE CANCER 1 0.0000
169 BALANCE DISORDER 1 0.0000
170 INTENTIONAL PRODUCT MISUSE 1 0.0000
171 TACHYCARDIA 1 0.0000
172 GASTROINTESTINAL DISORDER 1 0.0000
173 SUICIDAL IDEATION 1 0.0000
174 OROPHARYNGEAL PAIN 1 0.0000
175 HEART RATE INCREASED 1 0.0000
176 SYNCOPE 1 0.0000
177 CONDITION AGGRAVATED 3 0.0000
178 SINUSITIS 1 0.0000
179 DYSPNOEA 5 0.0000
180 INCORRECT DOSE ADMINISTERED 2 0.0000
181 PALPITATIONS 1 0.0000
182 OFF LABEL USE 7 0.0000
183 HYPERHIDROSIS 1 0.0000
184 PRODUCT QUALITY ISSUE 1 0.0000
185 INFECTION 1 0.0000
186 BLOOD PRESSURE INCREASED 1 0.0000
187 HEADACHE 4 0.0000
188 DRUG DOSE OMISSION 1 0.0000
189 DIZZINESS 3 0.0000
190 ABDOMINAL DISCOMFORT 1 0.0000
191 CEREBROVASCULAR ACCIDENT 1 0.0000
192 NO ADVERSE EVENT 1 0.0000
193 HYPERSENSITIVITY 1 0.0000
194 PRODUCT USE ISSUE 1 0.0000
195 GAIT DISTURBANCE 1 0.0000
196 HYPOTENSION 1 0.0000
197 HYPERTENSION 1 0.0000
198 WEIGHT INCREASED 1 0.0000
199 BACK PAIN 1 0.0000
200 VOMITING 2 0.0000
201 FEELING ABNORMAL 1 0.0000
202 FATIGUE 3 0.0000
203 INSOMNIA 1 0.0000
204 WEIGHT DECREASED 1 0.0000
205 ANXIETY 1 0.0000
206 INJECTION SITE PAIN 1 0.0000
207 ASTHENIA 1 0.0000
208 ARTHRALGIA 1 0.0000
209 MALAISE 1 0.0000
210 DIARRHOEA 1 0.0000
211 NAUSEA 1 0.0000